|
NEWEST ARTICLE
Mariantonietta Cicoira, Stefan D. Anker, Claudio Ronco
Cardio-renal cachexia syndromes (CRCS): pathophysiological foundations of a vicious pathological circle
Heart failure (HF) is a clinical condition associated with poor prognosis and high hospitalisation rates due to exacerbation of the disease. Concomitant kidney abnormalities are frequent: Only 7% of chronic HF patients have a preserved kidney function, with the majority of patients having mild to moderate impairment of glomerular filtration rate [3]. Furthermore, acute HF syndromes are frequently complicated by acute kidney injury (AKI).
In both chronic and acute settings of HF, many studies have shown that worsening renal function is associated with dismal prognosis. These conditions are generally grouped under the umbrella term cardio-renal syndromes (CRS).
|
ARTICLES
- Latest
-
The role of insulin resistance in the development of muscle wasting during cancer cachexia
Mary A. Honors, Kimberly P. Kinzig J Cachex Sarcopenia Muscle Online First 1 December 2011 |
|
The effect of exercise on IL-6-induced cachexia in the Apc Min/+ mouse
Melissa J. Puppa, James P. White, Kandy T. Velázquez, Kristen A. Baltgalvis, Shuichi Sato, John W. Baynes, James A. Carson J Cachex Sarcopenia Muscle Online First 30 November 2011 |
|
Myostatin blockage using actRIIB antagonism in mice bearing the Lewis lung carcinoma results in the improvement of muscle wasting and physical performance
Sílvia Busquets, Míriam Toledo, Marcel Orpí, David Massa und Maria Porta, et al.J Cachex Sarcopenia Muscle Online First 7 Novemberr 2011 |
|
Age- and gender-dependent values of skeletal muscle mass in healthy children and adolescents
Colin E. Webber, Ronald D. Barr J Cachex Sarcopenia Muscle Online First 30 October 2011 |
|
Ursodeoxycholic acid treatment in a rat model of cancer cachexia
Anika Tschirner, Stephan von Haehling, Sandra Palus, Wolfram Doehner, Stefan D. Anker, et al. J Cachex Sarcopenia Muscle Online First 21 October 2011 |
|
Molecular control of neuromuscular junction development.
Elisabetta Ferraro, Francesca Molinari, Libera Berghella J Cachex Sarcopenia Muscle Online First 13 October 2011 |
|
- Most Read
-
Last 90 Days
|
461
|
Elkina Y, von Haehling S, Anker SD, Springer J. The role of myostatin in muscle wasting: an overview. J Cachex Sarcopenia Muscle 2011;3:143 -151.
|
|
|
357
|
Abstracts of the 6th Cachexia Conference, Milan, Italy, December 8–10, 2011J Cachex Sarcopenia Muscle 2011;4:209-261
|
|
|
287
|
Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training
Lenk K, Schuler G, Adams V. Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. J Cachexia Sarcopenia Muscle 2010;1:9-21
|
|
|
273
|
Schefold JC, Bierbrauer J, Weber-Carstens S. Intensive care unit-acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock. J Cachexia Sarcopenia Muscle 2010;2:147-157.
|
|
|
241
|
Abstracts of the 5th Cachexia Conference, Barcelona, Spain, December 5–8, 2009
|
|
|
